Cargando…

The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?

Although cancer-associated fibroblasts (CAFs) have gained increased attention for supporting cancer progression, current CAF-targeted therapeutic options are limited and failing in clinical trials. As the largest component of the tumor microenvironment (TME), CAFs alter the biochemical and physical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brewer, Gabrielle, Fortier, Anne-Marie, Park, Morag, Moraes, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112234/ https://www.ncbi.nlm.nih.gov/pubmed/35600290 http://dx.doi.org/10.4155/fdd-2021-0004

Ejemplares similares

Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
por: Ghanbari, Faegheh, et al.
Publicado: (2021)

Cancer associated fibroblasts: An essential role in the tumor microenvironment
por: Tao, Leilei, et al.
Publicado: (2017)

Iron: An Essential Element of Cancer Metabolism
por: Hsu, Myriam Y., et al.
Publicado: (2020)

Esophagus cancer and essential trace elements
por: Yang, Xin, et al.
Publicado: (2022)

Essential Elements and Isoflavonoids in the Prevention of Prostate Cancer
por: Stanisławska, Iwona J., et al.
Publicado: (2022)

MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development
por: Harati, Sahar, et al.
Publicado: (2017)

Serum Essential Elements and Survival after Cancer Diagnosis
por: Lubiński, Jan, et al.
Publicado: (2023)

Searching for essential genes and drug discovery in breast cancer and periodontitis via text mining and bioinformatics analysis
por: Luo, Lan, et al.
Publicado: (2021)

Functional diversity of cancer‐associated fibroblasts in modulating drug resistance
por: Bu, Luke, et al.
Publicado: (2020)

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
por: Butti, Ramesh, et al.
Publicado: (2023)

The discovery of the heaviest elements
por: Hofmann, S, et al.
Publicado: (2000)

In silico drug combination discovery for personalized cancer therapy
por: Jeon, Minji, et al.
Publicado: (2018)

Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs
por: Brumskill, Sarah, et al.
Publicado: (2021)

Pharmacogenomics: Activating Cancer Drug Discovery
por: Mead, M. Nathaniel
Publicado: (2004)

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Biotechnology landscape in cancer drug discovery
por: Neagu, Monica, et al.
Publicado: (2015)

Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
por: Erdogan, Begum, et al.
Publicado: (2017)

Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements
por: Smith, Robin P., et al.
Publicado: (2014)

Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
por: McKay, Kyle, et al.
Publicado: (2022)

Apoptosis, senescence and cancer (cancer drug discovery and development)
por: Young, A
Publicado: (2009)

Cancer Drug Discovery and Development: Stem Cells and Cancer
por: Stewart, M H
Publicado: (2010)

Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast
por: Ochi, Kosuke, et al.
Publicado: (2022)

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
por: Yenerall, Paul, et al.
Publicado: (2021)

Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
por: Jiang, Guoqian, et al.
Publicado: (2015)

Berkeley: Discovery of element 105
Publicado: (1970)

Using the Culex pipiens sperm proteome to identify elements essential for mosquito reproduction
por: Thaler, Catherine D., et al.
Publicado: (2023)

RNA Editing and Drug Discovery for Cancer Therapy
por: Huang, Wei-Hsuan, et al.
Publicado: (2013)

Targeting autophagic pathways for cancer drug discovery
por: Liu, Bo, et al.
Publicado: (2013)

Natural radioprotectors and their impact on cancer drug discovery
por: Kuruba, Vinutha, et al.
Publicado: (2018)

The political economics of cancer drug discovery and pricing
por: Taylor, David G.
Publicado: (2020)

Targeting transcription factors in cancer drug discovery
por: Mitra, Partha
Publicado: (2020)

Emerging concepts in drug discovery for cancer therapy
por: Murga, Matilde, et al.
Publicado: (2022)

Reverse of microtubule-directed chemotherapeutic drugs resistance induced by cancer-associated fibroblasts in breast cancer
por: Li, Xuebo, et al.
Publicado: (2019)

Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
por: Zhang, Lulin, et al.
Publicado: (2018)

Essential Gene Discovery in the Basidiomycete Cryptococcus neoformans for Antifungal Drug Target Prioritization
por: Ianiri, Giuseppe, et al.
Publicado: (2015)

Striking essential oil: tapping into a largely unexplored source for drug discovery
por: Feyaerts, Adam F., et al.
Publicado: (2020)

Functional profiling of microtumors to identify cancer associated fibroblast-derived drug targets
por: Horman, Shane R., et al.
Publicado: (2017)

Biomarkers for cancer-associated fibroblasts
por: Han, Chencheng, et al.
Publicado: (2020)

The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation
por: Newman, Andrew C., et al.
Publicado: (2011)

Stretching Fibroblasts Remodels Fibronectin and Alters Cancer Cell Migration
por: Ao, Mingfang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_99ncc95hksjm8mch98vo0racv7